MedPath

Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Recruiting
Conditions
Microplastics
Chronic Kidney Diseases
Nanoplastics
Genotoxic Damage
Interventions
Other: Biomonitoring study to detect MNPLs in biological samples and study of their health effects
Registration Number
NCT05155267
Lead Sponsor
Ricard Marcos
Brief Summary

Micro and nanoplastics (MNPLs) effects on human heath is still preliminary. Chronic kidney disease (CKD) participants, specially does patients submitted to hemodialysis, are a population high exposed to plastics. The objective of our research is to be able to detect MNPLs on biological fluids of hemodialysis patients as well as their potential genotoxic and immunological damage.

Detailed Description

The exponential increase in the production/use of plastic translates into a parallel increase of environmental plastic-waste that is continuously degraded into micro and nanoplastics (MNPLs). Information on the MNPLs' effects on human health is still preliminary and, furthermore, the limitations in current methodologies prevent accurate human exposure/risk assessment.

The study aims to analyse specific biomarkers of exposure to MNPLs in humans, as well as biomarkers of genetic damage, which will allow an association between exposure to these plastic materials and the optimisation of different techniques for the detection and characterisation of MNPLs.

The study will evaluate the effect of exposure to MNPLs, analysing the genotoxic damage, different biomarkers of exposure and the effects on microbiota, in different body samples (urine, blood and feces).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chronic Kidney disease participants (CKD)_HDBiomonitoring study to detect MNPLs in biological samples and study of their health effectsCKD submitted to hemodialysis (HD)
Chronic Kidney disease participants (CKD)_PDBiomonitoring study to detect MNPLs in biological samples and study of their health effectsCKD non-submitted to hemodialysis (pre-dialysis:PD)
ControlsBiomonitoring study to detect MNPLs in biological samples and study of their health effectsHealthy participants
Primary Outcome Measures
NameTimeMethod
Biomonitoring study to detect the presence of MNPLs in biological fluidsUp to 1 year

Micro and nanoplastic and/or derivatives, would be evaluated. Characterization of possible biomarkers of early biological effects on human health

Study of the effects of MNPLs on immune systemUp to 1 year

Impact evaluation of MNPLs on transcriptome, secretome and inflammatory signalling and inflammasome activation. Investigating the effect of MNPLs on the function of the immune system in vivo and in high-risk individuals

Genotoxicity effects of exposure to MNPLsUp to 1 year

Genotoxic, chromosome damage evaluation and oxidative DNA damage will be analysed by the Comet assay and the micronucleus assay

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Servicio Murciano de Salud

🇪🇸

Murcia, Spain

© Copyright 2025. All Rights Reserved by MedPath